{
    "eid": "2-s2.0-85101743624",
    "title": "ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia",
    "cover-date": "2021-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "ABCB1 polymorphism",
        "biomarker",
        "chemotherapy response",
        "Low-risk gestational trophoblastic neoplasia",
        "methotrexate",
        "personalized treatment",
        "post-molar gestational trophoblastic neoplasia",
        "predicting methotrexate resistant",
        "single nucleotide polymorphism",
        "SLCO1B1 polymorphism"
    ],
    "authors": [
        "Manasawee Srisuttayasathien",
        "Nutthada Areepium",
        "Ruangsak Lertkhachonsuk"
    ],
    "citedby-count": 1,
    "ref-count": 39,
    "ref-list": [
        "First-line chemotherapy in low-risk gestational trophoblastic neoplasia",
        "Royal College of Obstetricians and Gynaecologists",
        "Treatment outcomes of gestational trophoblastic neoplasia in king chulalongkorn memorial hospital over two decades",
        "A 10-year clinical experience of gestational trophoblastic disease at Rajavithi hospital, 2001-2010",
        "The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment",
        "Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up",
        "Actinomycin D versus methotrexate-folinic acid as the treatment of Stage I, low-risk gestational trophoblastic neoplasia",
        "A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom",
        "Treatment of low-risk gestational trophoblastic neoplasia",
        "Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-Agent chemotherapy",
        "Risk adapted single-Agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia",
        "Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009",
        "Optimal management of low-risk gestational trophoblastic neoplasia",
        "Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia",
        "Resistance to single-Agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms",
        "Pharmacotherapy of gestational trophoblastic disease",
        "Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia",
        "Pharmacogenomics of methotrexate membrane transport pathway: Can clinical response to methotrexate in rheumatoid arthritis be predicted?",
        "Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis",
        "PharmGKB summary: Methotrexate pathway",
        "Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma",
        "ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients",
        "Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritisAssoziation des ABCB1-C3435T-Polymorphismus mit dem Ansprechen auf DMARDs sowie deren Toxizit\u00e4t bei rheumatoider Arthritis",
        "Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects",
        "Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia",
        "Association between ABCB1 C3435T polymorphism and methotrexate treatment outcomes in rheumatoid arthritis patients: A meta-Analysis",
        "667C T and 1298A C polymorphisms of MTHFR do not predict response to methotrexate in patients with gestational trophoblastic neoplasia",
        "Development of single-Agent chemotherapy regimens for gestational trophoblastic disease",
        "National Institute of Cancer",
        "On behalf of the Statistical Methods Group of the Cochrane Collaboration",
        "Chapter 15 Contingency Table",
        "Comparison of cost-effectiveness between actinomycin D versus methotrexate-folinic acid in the treatment of low-risk gestational trophoblastic neoplasia",
        "Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience",
        "Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia",
        "The efficacy and safety of first-line single-Agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-Analysis",
        "An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275",
        "Quality of life in gestational trophoblastic neoplasia wpatients after treatment in Thailand",
        "Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide",
        "Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chula-longkorn University",
        "Ratchadaphiseksomphot Fund",
        "Chulalongkorn University and Placental Related Diseases Research Unit"
    ]
}